Coya Therapeutics, Inc.COYANASDAQ
Loading
COYA Revenue Growth (YoY Quarterly)•+202768.80%
Stock Alarm Pro
Growth Metrics
Latest: Q4 2025vs Q3 2025
Revenue GrowthGross Profit GrowthEBITDA GrowthOperating Income GrowthNet Income GrowthEPS GrowthEPS Diluted GrowthWeighted Average Shares GrowthWeighted Average Shares Diluted GrowthDividends per Share Growth
+202768.80%
+202768.8pp
+0.00%
+0.0pp
+0.00%
+0.0pp
+0.00%
+0.0pp
+0.00%
+0.0pp
+0.00%
+0.0pp
+0.00%
+0.0pp
+2.28%
-7.7pp
+2.28%
-7.7pp
+0.00%
+0.0pp
| Metric | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 |
|---|---|---|---|---|---|
| Revenue Growth | -99.97% | +103.32% | -95.22% | +0.00% | +202768.80% |
| Gross Profit Growth | -144.06% | +0.00% | +0.00% | +0.00% | +0.00% |
| EBITDA Growth | -302.14% | +0.00% | +0.00% | +0.00% | +0.00% |
| Operating Income Growth | -324.79% | +0.00% | +0.00% | +0.00% | +0.00% |
| Net Income Growth | -330.32% | +0.00% | +0.00% | +0.00% | +0.00% |
| EPS Growth | -250.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| EPS Diluted Growth | -250.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Weighted Average Shares Growth | +60.93% | +15.65% | +12.14% | +9.93% | +2.28% |
| Weighted Average Shares Diluted Growth | +60.93% | +15.65% | +12.14% | +9.93% | +2.28% |
| Dividends per Share Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Operating Cash Flow Growth | +0.00% | -231.80% | +0.00% | +0.00% | +0.00% |
| Free Cash Flow Growth | +0.00% | -231.80% | +0.00% | +0.00% | +0.00% |
| Receivables Growth | -90.26% | +0.00% | +0.00% | +0.00% | -100.00% |
| Inventory Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Asset Growth | +7.48% | +2.71% | -16.24% | -9.87% | +12.63% |
| Book Value per Share Growth | -30.99% | -10.93% | -28.39% | -22.46% | +6.29% |
| Debt Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| R&D Expense Growth | +7.47% | +64.84% | +80122.98% | +31.16% | +155.00% |
| SG&A Expenses Growth | -10.07% | +11.23% | +139154.23% | +15.22% | -135837.03% |
1 / 4